NCT06509633 Effects of Pain Neuroscience Education and Standard Rehabilitation Regime in Patients of Carpal Tunnel Syndrome
| NCT ID | NCT06509633 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Wrist Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2024-10-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-02-01 with a primary completion date of 2024-10-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to check the effects of Pain Neuroscience education and standard rehabilitation regime in patients of carpal tunnel syndrome.
Eligibility Criteria
Inclusion Criteria: * age between 20\_40 years old. * Medical diagnosis of moderate to severe CTS. * Symptoms of CTS since 1month * Unilateral or bilateral symptoms * Availability and access to the hospital. Exclusion Criteria: * Inability to understand instructions, neurological conditions of the central nervous system (e.g. stroke, spinal cord injury) * Patients on treatment with alternative therapies * Previous participation in a research program * Previous surgery on the affected upper limb
Contact & Investigator
Saba khan
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06509633 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 50 Years, studying Wrist Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06509633 currently recruiting?
Yes, NCT06509633 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06509633 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06509633 clinical trial?
NCT06509633 is sponsored by Riphah International University. The principal investigator is Saba khan at Riphah International University. The trial plans to enroll 30 participants.